Heavy Strength Training in Head and Neck Cancer Survivors
Launched by UNIVERSITY OF ALBERTA · Feb 28, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The LIFTING 2 trial is a clinical study designed to explore the effects of heavy strength training on survivors of head and neck cancer. Many people who have had this type of cancer experience ongoing challenges, such as weakness, fatigue, and difficulty swallowing, which can impact their daily lives and overall happiness. This trial aims to see if a more intense strength training program can help improve these issues compared to no exercise at all.
To participate in this study, individuals must be at least 18 years old and have completed their cancer treatment at least a year ago. They should also be cleared for exercise by their doctor and meet certain physical requirements. Participants will engage in a structured strength training program and can expect to receive support and guidance throughout the process. This trial is open to all genders and aims to help improve the quality of life for head and neck cancer survivors. If you or someone you know is interested, it's a great opportunity to contribute to important research while potentially benefiting from the exercise program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • males and females, 18 years of age and older
- • any head and neck cancer subtype, stage, and treatment type
- • at least 1-year posttreatment with adequate shoulder range of motion (must meet minimum cutpoints for active flexion and abduction to be eligible)
- • no unmanaged medical conditions, alcohol, or drug abuse
- • approved for exercise by oncologist and a certified exercise physiologist or kinesiologist
- • ability to understand and communicate in English
- Exclusion Criteria:
- • has met the Canadian Physical Activity strength training guidelines within the past one-month: at least two days per week of muscle and bone strength training activities using major muscle groups
- • currently involved in a different exercise trial or clinical drug trial
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Kerry Courneya
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported